miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.

By M. Garofalo, Gianpiero di Leva, G. Romano, G. Nuovo, S. Suh, Apollinaire Ngankeu, Cristian Taccioli, F. Pichiorri, H. Alder, P. Secchiero and 6 more. Cancer Cell, 2009

815 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/d5f71dd86e4c7e8db71462f9f64a4247bd885d37

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Carlo Maria Croce
2. George A. Calin
3. Marilena V. Iorio
4. Manel Esteller

In Molecular Biology

1. Carlo Maria Croce
2. George A. Calin
3. Marilena V. Iorio
4. Manel Esteller

Citations in the corpus

• Causes and consequences of microRNA dysregulation in cancer (2009, background): “For example, miR-21 has been found to target PTEN, programmed cell death 4 (PDCD4), TIMP1 and TIMP3 (Ref”
• Molecular and genetic properties of tumors associated with local immune cytolytic activity (2015, neutral): “, 2014),MET (Fan et al., 2001; Garofalo et al., 2009),CSNK2A1 (Ravi and Bedi, 2002; Izeradjene et al.”